Skip to content
Sanofi and University Hospital Toulouse

Sanofi and University Hospital Toulouse

Lixisenatide is a peptide GLP-1 agonist, working in the same pathway as exenatide and liraglutide. It is being investigated for its ability to regulate cellular metabolism, reduce inflammation, and possibly slow the progression of neurodegenerative diseases.

Cart 0

Your cart is currently empty.

Start Shopping